Furthermore, high numbers of Fraction 2 Treg cells, low numbers of CD8+ T cells (i.e., non-inflamed condition), and high levels of CCL22 (the main ligand for CCR4) are observed in EGFR-mutated NSCLC patients[103]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.